Publications by Anette Weyergang

33 publications found

Publications 2018

  1. Eng MS, Kaur J, Prasmickaite L, Engesæter BØ, Weyergang A, Skarpen E, Berg K, Rosenblum MG, Mælandsmo GM, Høgset A, Ferrone S, Selbo PK (2018)
    Enhanced targeting of triple-negative breast carcinoma and malignant melanoma by photochemical internalization of CSPG4-targeting immunotoxins
    Photochem Photobiol Sci, 17 (5), 539-551
    DOI 10.1039/C7PP00358G, PubMed 29565434
  2. Weyergang A, Fremstedal AS, Skarpen E, Peng Q, Mohamedali KA, Eng MS, Cheung LH, Rosenblum MG, Waltenberger J, Berg K (2018)
    Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy
    J Control Release, 288, 161-172
    DOI 10.1016/j.jconrel.2018.09.005, PubMed 30217739

Publications 2017

  1. Norum OJ, Fremstedal ASV, Weyergang A, Golab J, Berg K (2017)
    Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity
    J Control Release, 268, 120-127
    DOI 10.1016/j.jconrel.2017.10.015, PubMed 29042319
  2. Olsen CE, Weyergang A, Edwards VT, Berg K, Brech A, Weisheit S, Høgset A, Selbo PK (2017)
    Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: Possible mechanisms and approaches for overcoming PDT-resistance
    Biochem Pharmacol, 144, 63-77
    DOI 10.1016/j.bcp.2017.08.002, PubMed 28784290

Publications 2015

  1. Berstad MB, Cheung LH, Berg K, Peng Q, Fremstedal AS, Patzke S, Rosenblum MG, Weyergang A (2015)
    Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy
    Oncogene, 34 (44), 5582-92
    DOI 10.1038/onc.2015.15, PubMed 25684137
  2. Bull-Hansen B, Berstad MB, Berg K, Cao Y, Skarpen E, Fremstedal AS, Rosenblum MG, Peng Q, Weyergang A (2015)
    Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer
    Oncotarget, 6 (14), 12436-51
    DOI 10.18632/oncotarget.3814, PubMed 26002552
  3. Selbo PK, Bostad M, Olsen CE, Edwards VT, Høgset A, Weyergang A, Berg K (2015)
    Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics
    Photochem Photobiol Sci, 14 (8), 1433-50
    DOI 10.1039/c5pp00027k, PubMed 25805311
  4. Weyergang A, Berstad ME, Bull-Hansen B, Olsen CE, Selbo PK, Berg K (2015)
    Photochemical activation of drugs for the treatment of therapy-resistant cancers
    Photochem Photobiol Sci, 14 (8), 1465-75
    DOI 10.1039/c5pp00029g, PubMed 25849953

Publications 2014

  1. Bostad M, Kausberg M, Weyergang A, Olsen CE, Berg K, Høgset A, Selbo PK (2014)
    Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization
    Mol Pharm, 11 (8), 2764-76
    DOI 10.1021/mp500129t, PubMed 24960585
  2. Bull-Hansen B, Cao Y, Berg K, Skarpen E, Rosenblum MG, Weyergang A (2014)
    Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome
    J Control Release, 182, 58-66
    DOI 10.1016/j.jconrel.2014.03.014, PubMed 24637464
  3. Weyergang A, Cheung LH, Rosenblum MG, Mohamedali KA, Peng Q, Waltenberger J, Berg K (2014)
    Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF(121)/rGel fusion toxin
    J Control Release, 180, 1-9
    DOI 10.1016/j.jconrel.2014.02.003, PubMed 24531010

Publications 2013

  1. Olsen CE, Berg K, Selbo PK, Weyergang A (2013)
    Circumvention of resistance to photodynamic therapy in doxorubicin-resistant sarcoma by photochemical internalization of gelonin
    Free Radic Biol Med, 65, 1300-1309
    DOI 10.1016/j.freeradbiomed.2013.09.010, PubMed 24076428
  2. Vikdal M, Weyergang A, Selbo PK, Berg K (2013)
    Vascular endothelial cells as targets for photochemical internalization (PCI)
    Photochem Photobiol, 89 (5), 1185-92
    DOI 10.1111/php.12126, PubMed 23819771
  3. Weyergang A, Selbo PK, Berg K (2013)
    Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy
    Biochim Biophys Acta, 1830 (3), 2659-70
    DOI 10.1016/j.bbagen.2012.11.010, PubMed 23671927
  4. Weyergang A, Selbo PK, Berg K (2013)
    Sustained ERK inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy (vol 1830, pg 2659, 2013)
    Biochim. Biophys. Acta-Gen. Subj., 1830 (10), 4417

Publications 2012

  1. Berstad MB, Weyergang A, Berg K (2012)
    Photochemical internalization (PCI) of HER2-targeted toxins: synergy is dependent on the treatment sequence
    Biochim Biophys Acta, 1820 (12), 1849-58
    DOI 10.1016/j.bbagen.2012.08.027, PubMed 22981913
  2. Selbo PK, Weyergang A, Eng MS, Bostad M, Mælandsmo GM, Høgset A, Berg K (2012)
    Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug
    J Control Release, 159 (2), 197-203
    DOI 10.1016/j.jconrel.2012.02.003, PubMed 22349185

Publications 2011

  1. Weyergang A, Selbo PK, Berstad ME, Bostad M, Berg K (2011)
    Photochemical internalization of tumor-targeted protein toxins
    Lasers Surg Med, 43 (7), 721-33
    DOI 10.1002/lsm.21084, PubMed 22057500

Publications 2010

  1. Berg K, Berstad M, Prasmickaite L, Weyergang A, Selbo PK, Hedfors I, Høgset A (2010)
    Photochemical internalization: a new tool for gene and oligonucleotide delivery
    Top Curr Chem, 296, 251-81
    DOI 10.1007/128_2010_63, PubMed 21504105
  2. Berg K, Weyergang A, Prasmickaite L, Bonsted A, Høgset A, Strand MT, Wagner E, Selbo PK (2010)
    Photochemical internalization (PCI): a technology for drug delivery
    Methods Mol Biol, 635, 133-45
    DOI 10.1007/978-1-60761-697-9_10, PubMed 20552345
  3. Selbo PK, Weyergang A, Høgset A, Norum OJ, Berstad MB, Vikdal M, Berg K (2010)
    Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules
    J Control Release, 148 (1), 2-12
    DOI 10.1016/j.jconrel.2010.06.008, PubMed 20600406

Publications 2009

  1. Norum OJ, Selbo PK, Weyergang A, Giercksky KE, Berg K (2009)
    Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine
    J Photochem Photobiol B, 96 (2), 83-92
    DOI 10.1016/j.jphotobiol.2009.04.012, PubMed 19467605
  2. Weyergang A, Berg K, Kaalhus O, Peng Q, Selbo PK (2009)
    Photodynamic therapy targets the mTOR signaling network in vitro and in vivo
    Mol Pharm, 6 (1), 255-64
    DOI 10.1021/mp800156e, PubMed 19125612

Publications 2008

  1. Weyergang A, Kaalhus O, Berg K (2008)
    Photodynamic therapy with an endocytically located photosensitizer cause a rapid activation of the mitogen-activated protein kinases extracellular signal-regulated kinase, p38, and c-Jun NH2 terminal kinase with opposing effects on cell survival
    Mol Cancer Ther, 7 (6), 1740-50
    DOI 10.1158/1535-7163.MCT-08-0020, PubMed 18566245
  2. Weyergang A, Kaalhus O, Berg K (2008)
    Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478
    Photochem Photobiol Sci, 7 (9), 1032-40
    DOI 10.1039/b806209a, PubMed 18754049

Publications 2007

  1. Berg K, Folini M, Prasmickaite L, Selbo PK, Bonsted A, Engesaeter BØ, Zaffaroni N, Weyergang A, Dietze A, Maelandsmo GM, Wagner E, Norum OJ, Høgset A (2007)
    Photochemical internalization: a new tool for drug delivery
    Curr Pharm Biotechnol, 8 (6), 362-72
    DOI 10.2174/138920107783018354, PubMed 18289045
  2. Weyergang A, Selbo PK, Berg K (2007)
    Y1068 phosphorylation is the most sensitive target of disulfonated tetraphenylporphyrin-based photodynamic therapy on epidermal growth factor receptor
    Biochem Pharmacol, 74 (2), 226-35
    DOI 10.1016/j.bcp.2007.04.018, PubMed 17531956
  3. Yip WL, Weyergang A, Berg K, Tønnesen HH, Selbo PK (2007)
    Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells
    Mol Pharm, 4 (2), 241-51
    DOI 10.1021/mp060105u, PubMed 17263556

Publications 2006

  1. Berg K, Høgset A, Prasmickaite L, Weyergang A, Bonsted A, Dietze A, Lou PJ, Bown S, Norum OJ, Møllergard HM, Selbo PK (2006)
    Photochemical internalization (PCI): A novel technology for activation of endocytosed therapeutic agents.
    Med Laser Appl, 21, 239-251
    DOI 10.1016/j.mla.2006.08.004, PublikaID 73
  2. Dietze A, Selbo PK, Prasmickaite L, Weyergang A, Bonsted A, Engesaeter B, Hogset A, Berg K (2006)
    Photochemical internalization (PCI): a new modality for light activation of endocytosed therapeuticals
    J Environ Pathol Toxicol Oncol, 25 (1-2), 521-36
    DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.330, PubMed 16566739
  3. Selbo PK, Weyergang A, Bonsted A, Bown SG, Berg K (2006)
    Photochemical internalization of therapeutic macromolecular agents: a novel strategy to kill multidrug-resistant cancer cells
    J Pharmacol Exp Ther, 319 (2), 604-12
    DOI 10.1124/jpet.106.109165, PubMed 16902053
  4. Weyergang A, Selbo PK, Berg K (2006)
    Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin
    J Control Release, 111 (1-2), 165-73
    DOI 10.1016/j.jconrel.2005.12.002, PubMed 16466823

Publications 2005

  1. Berg K, Selbo PK, Weyergang A, Dietze A, Prasmickaite L, Bonsted A, Engesaeter BØ, Angell-Petersen E, Warloe T, Frandsen N, Høgset A (2005)
    Porphyrin-related photosensitizers for cancer imaging and therapeutic applications
    J Microsc, 218 (Pt 2), 133-47
    DOI 10.1111/j.1365-2818.2005.01471.x, PubMed 15857375
 
Page visits: 720